<?xml version="1.0"  encoding="iso-8859-1"?>
<rss version="2.0">
	<channel>
		<title>Liste des Publications du CIRC disponibles au format pdf</title>
		<link>http://www.iarc.fr/fr/feeds/pub_pdf/feeds.xml</link>
		<description>This channel provides the most recent IARC Publications available in PDF format</description>
		<language>fr</language>
		<pubDate>Tue, 29 Mar 2011 13:00:00 GMT</pubDate>
		<generator>Sitemapdoc.com XML Sitemap Generator</generator>
		<item>
			<title>IARC Working Group Reports; 6 - Current status and future directions of breast and cervical cancer prevention and early detection in Belarus</title>
			<link>http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk6/index.php</link>
			<pubDate>Wed, 4 Apr 2012 13:25:00 GMT</pubDate>
			<description>At the request of the Belarusian Minister of Health, a WHO/IARC expert mission was conducted in the city of Minsk and in the Minsk District from 15 to 18 February 2011. The purpose of the mission was to evaluate the current status of breast and cervical cancer prevention and early detection in Belarus and to develop recommendations for improvement.</description>
		</item>
		
		<item>
			<title>Pathology and Genetics of Tumours of the Breast and Female Genital Organs</title>
			<link>http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb4/index.php</link>
			<pubDate>Tue, 18 Oct 2011 12:25:00 GMT</pubDate>
			<description>Pathology and Genetics of Tumours of the Breast and Female Genital Organs is now available in PDF format. This book covers the female and male breast, ovaries, fallopian tumours, uterine cervix, uterine corpus, vulva, vagina and inherited tumour syndromes.</description>
		</item>
		<item>
			<title>IARC Monographs - Volume 100 - Part A,B,C,D,E,F</title>
			<link>http://apps.who.int/bookorders/anglais/detart1.jsp?sesslan=1&amp;codlan=1&amp;codcol=72&amp;codcch=100</link>
			<pubDate>Mon, 23 May 2011 16:42:00 GMT</pubDate>
			<description>Volume 100 compiles information on tumour sites and mechanisms of carcinogenesis. About half of the agents classified in Group 1 were last reviewed more than 20 years ago, before mechanistic studies became prominent in evaluations of carcinogenicity.</description>
		</item>	
		
	</channel>
</rss>